Search for: "Sanofi"
Results 21 - 40
of 1,186
Sorted by Relevance
|
Sort by Date
15 Dec 2008, 9:51 pm
Sanofi-Synthelabo et al. v. [read post]
1 Jun 2009, 9:03 pm
Sanofi-Aventis bought BiPar to obtain rights to BiPar's BSI-201, which belongs to a new class of drugs that block a cell repair enzyme known as PARP. [read post]
30 Jun 2010, 3:50 am
Sanofi-Aventis, France's largest drugmaker, agreed to buy closely held TargeGen to add treatments for certain forms of leukemia and blood disorders, Bloomberg News reported. [read post]
28 Jul 2010, 3:47 pm
Sanofi-Aventis is likely to make an unsolicited offer of up to $70 a share for Genzyme, raising the stakes for what could become one of the year's biggest deal situations, people briefed on the matter told DealBook on Wednesday. [read post]
1 Feb 2011, 11:38 am
Sanofi intends to add a few dollars a share to its $69-a-share offer, and will likely allow for additional payments to Genzyme shareholders if one of the company's drugs hits certain sales expectations. [read post]
10 Sep 2010, 2:03 am
French drugmaker Sanofi-Aventis poured cold water on reports it had raised its offer for Genzyme, saying it was sticking to its bid of $18.5 billion, or $69 per share, Reuters reported. [read post]
10 May 2023, 12:15 pm
Mylan Pharmaceuticals petitioned the PTAB for inter partes review (IPR) of all 18 claims in Sanofi’s drug injector pen patent. [read post]
10 May 2023, 12:15 pm
Mylan Pharmaceuticals petitioned the PTAB for inter partes review (IPR) of all 18 claims in Sanofi’s drug injector pen patent. [read post]
30 Jun 2021, 5:27 am
Sanofi is not the only drug company in hot water. [read post]
30 Jun 2021, 5:27 am
Sanofi is not the only drug company in hot water. [read post]
30 Jun 2021, 5:27 am
Sanofi is not the only drug company in hot water. [read post]
18 Jun 2008, 11:05 am
French drugmaker Sanofi-Aventis plans to make a 40.04 billion Czech crown ($2.57 billion) offer for Czech drugmaker Zentiva, trumping a bid from financial group PPF. [read post]
27 Mar 2007, 5:07 am
A deal between Sanofi-Aventis, France’s largest drug company, and U.S. rival Bristol-Myers Squibb could still be in the offing. [read post]
10 Nov 2010, 1:46 pm
A state statute and a 2006 proxy vote by Genzyme add an interesting twist to a hostile takeover bid by Sanofi-Aventis and help to illustrate the difficulties of making a bid for a Massachusetts corporation. [read post]
23 Jul 2010, 1:38 pm
Sanofi-Aventis has made an informal takeover approach to Genzyme, a person briefed on the matter told DealBook on Friday, as the French drug maker seeks to bolster its biotechnology offerings. [read post]
26 Nov 2010, 2:59 am
Henri Termeer of Genzyme told Le Figaro that he was not against Sanofi-Aventis's $18.5 billion takeover offer in principle, he just thinks it should be higher. [read post]
7 Oct 2010, 2:38 pm
Genzyme said Thursday that its board had again rejected an $18.5 billion takeover offer from Sanofi-Aventis of France, saying the bid remains too low. [read post]
5 Feb 2011, 8:18 pm
Reuters is reporting that Genzyme and Sanofi's respective boards will be meeting on Sunday. [read post]
20 Oct 2010, 7:05 am
Sanofi filed its patent-infringement suit against closely held Apotex in 2002 and won a preliminary injunction against the Toronto-based company four years later. [read post]
15 Feb 2011, 12:36 pm
Sanofi-Aventis is poised to raise its bid for Genzyme to about $74 a share, and a deal could be announced as soon as Wednesday. [read post]
